Holen Sie sich die Stockscreener-App
1.865
1.06%
-0.025
Schlusskurs vom Vortag:
$1.89
Offen:
$1.92
24-Stunden-Volumen:
482.48K
Relative Volume:
0.41
Marktkapitalisierung:
$174.79M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.2774
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
+2.75%
1M Leistung:
+18.35%
6M Leistung:
+3.89%
1J Leistung:
+89.75%
1-Tages-Spanne:
$1.84
$1.93
1-Wochen-Bereich:
$1.79
$2.06
52-Wochen-Spanne:
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.87 | 176.65M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.55 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.20 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
704.60 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.89 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Caribou Biosciences: Advancing Allogeneic Cell Therapy Pipeline and Pivotal Trial Plans Support High-Risk Buy Rating - TipRanks
Caribou Biosciences Q3 Losses Reinforce Bearish Narratives On Profitability Risks - Sahm
Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access - TipRanks
Truist reiterates Buy on Caribou Biosciences stock, $7 target - Investing.com Australia
Truist reiterates Buy on Caribou Biosciences stock, $7 target By Investing.com - Investing.com UK
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Caribou Biosciences announces Q4 and FY2025 financial results - Traders Union
Caribou Biosciences Q4 licensing revenue rises, net loss narrows - TradingView
Insights into Caribou Biosciences Q4 Earnings - Benzinga
Caribou Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
CRBU: Strong clinical progress and improved financials position the pipeline for pivotal trials - TradingView
BRIEF-Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million - TradingView
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - Stocktwits
CRBU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Caribou Biosciences (CRBU) to Release Earnings on Monday - MarketBeat
Insider Sell: Timothy Kelly Sells Shares of Caribou Biosciences Inc (CRBU) - GuruFocus
Caribou Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Caribou Biosciences (CRBU) CTO sells 6,228 shares in open-market trade - Stock Titan
7 Top Gene-Editing Stocks to Buy - US News Money
Caribou Biosciences (NASDAQ: CRBU) notice to sell 6,938 vested shares - Stock Titan
Caribou Biosciences (NASDAQ: CRBU) files Rule 144 to sell 6,938 shares - Stock Titan
Timothy Kelly sells 3,147 CRBU shares; proposed sale of 6,228 restricted shares (CRBU) - Stock Titan
Decliners Report: Is Roivant Sciences Ltd stock undervalued right nowJuly 2025 Update & Daily Growth Stock Tips - baoquankhu1.vn
Caribou Biosciences CLO sold $13,598 in CRBU stock - Investing.com UK
Caribou Biosciences (NASDAQ:CRBU) Insider Ruhi Ahmad Khan Sells 6,938 Shares - MarketBeat
Caribou Biosciences CLO sold $13,598 in CRBU stock By Investing.com - Investing.com Canada
Caribou Biosciences CTO Kelly sells $6.1k in shares By Investing.com - Investing.com Canada
Khan, Caribou Biosciences CBO, sells $13598 in stock - Investing.com Australia
Khan, Caribou Biosciences CBO, sells $13598 in stock By Investing.com - Investing.com Canada
Caribou Biosciences (CRBU) CBO awarded stock options, sells shares for tax - Stock Titan
[Form 4] Caribou Biosciences, Inc. Insider Trading Activity - Stock Titan
Growth Value: Is Caribou Biosciences Inc benefiting from interest rate changesMarket Risk Report & Intraday High Probability Alerts - baoquankhu1.vn
Earnings Risk: Is Magyar Bancorp Inc stock a falling knife or bargain buyJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn
Caribou Biosciences Details Pivotal-Ready Vispa-cel Plan, Flags Need for More Capital at Citi Summit - MarketBeat
Should you avoid Caribou Biosciences Inc. stock right now2025 Earnings Impact & Weekly Watchlist for Consistent Profits - mfd.ru
Volume Report: Is NCIQ stock forming a cup and handleSwing Trade & Weekly High Potential Alerts - baoquankhu1.vn
Short Squeeze: How does Caribou Biosciences Inc compare to its peersInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Caribou Biosciences (CRBU)’s CB-011 may reach $734 million in peak 2040 sales, according to Clear Street - MSN
Director at Caribou Biosciences (CRBU) awarded option for 45,000 shares - Stock Titan
Caribou Biosciences (CRBU) CEO receives large new equity grants - Stock Titan
Is Caribou Biosciences Inc. stock a top performer YTDWeekly Trade Report & Low Drawdown Momentum Trade Ideas - mfd.ru
Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Yahoo Finance
Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Finviz
Is Caribou Biosciences Inc. stock risky to hold nowJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
Can Caribou Biosciences Inc. stock hit record highs again2025 Key Highlights & AI Powered Market Trend Analysis - mfd.ru
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost Per Sample - marketscreener.com
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample - BioSpace
Will Caribou Biosciences Inc. stock benefit from infrastructure spendingQuarterly Profit Report & Real-Time Volume Spike Alerts - mfd.ru
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):